Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil
Cerebrovascular disease is the third leading cause of death and the leading cause of disability in Cuba and in several developed countries. A possible neuroprotective agent is the rHu-EPO, whose effects have been demonstrated in models of brain ischemia. The Neuro-EPO is a derivative of the rHu-EPO...
Main Authors: | Iliana Sosa Teste, Yuneidys Mengana Tamos, Yamila Rodríguez Cruz, Adriana Muñoz Cernada, Janette Cruz Rodríguez, Nelvis Subirós Martínez, Rosa Maria Coro Antich, Alina González-Quevedo, Julio Cesar García Rodríguez |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2012/607498 |
Similar Items
-
Treatment with Nasal Neuro-EPO Improves the Neurological, Cognitive, and Histological State in a Gerbil Model of Focal Ischemia
by: Yamila Rodríguez Cruz, et al.
Published: (2010-01-01) -
Sensibilidad de los modelos de isquemia global y focal en el gerbil de Mongolia.
by: Iliana Sosa Testé, et al.
Published: (2005-01-01) -
Alternativa terapeutica en la isquemia cerebral empleando la Eritropoyetina humana recombinante (rHu-EPO CIM) como neuroprotector.
by: Iliana Sosa Testé, et al.
Published: (2005-01-01) -
Neuroprotective effect of Neuro-EPO in neurodegenerative diseases: “Alea jacta est”
by: Ramón Rama, et al.
Published: (2019-01-01) -
Neuroprotective Effects of neuroEPO Using an In Vitro Model of Stroke
by: Garzón Fernando, et al.
Published: (2018-02-01)